Who Owns Pacira?
Pacira is a pharmaceutical brand owned by Pacira BioSciences, Inc. (Nasdaq: PCRX), pending a $1.65 billion acquisition by Viatris announced October 8, 2026. Founded in 2006 and headquartered in Brisbane, California, Pacira's products include EXPAREL surgical anesthetic and ZILRETTA osteoarthritis injection, both marketed as non-opioid alternatives for pain management.
Parent Company
Founded
2006
Status
Publicly Traded
Headquarters
Who Owns Pacira?
- Parent Company: Pacira BioSciences, Inc.
- Ownership Type: Independent
- Company Type: Publicly Traded
- Stock Ticker: Nasdaq: PCRX
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Pacira | Pacira BioSciences, Inc. | Independent |
Where to Buy
Disclosure: We may earn commission from purchases
Pacira on AmazonAdvertisement
About Pacira BioSciences, Inc.
American pharmaceutical company focused on non-opioid pain therapies including EXPAREL and ZILRETTA, being acquired by Viatris for $1.65 billion in a deal announced October 2026.
- Founded: 2006
- Headquarters: Brisbane, California, USA
- Company Type: Publicly Traded
- Stock: Nasdaq: PCRX
- Revenue: approximately $746 million (LTM to June 30, 2026)
Where Is Pacira Made / Based?
- Headquarters: Brisbane, California, USA
- Manufacturing / Operations: United States
Pacira Categories & Tags
Sources & Further Reading
- [Pacira Official Website](
- Viatris press release (October 8, 2026)
- SEC EDGAR: Pacira BioSciences, Inc. filings
Advertisement
Competitors to Pacira
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Amgen | USA | 1980 | Market leader | Global | All-ages | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders | |
| Amgen | USA (parent) | 2014 | Market leader | Global | All-ages | |
| Amgen | USA (parent) | 2010 | Market leader | Global | All-ages | |
| Teva | Israel | 1901 | Leader | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Healthcare PharmaceuticalsGE Diagnostics
Owned by GE HealthCare Technologies Inc.
Pharmaceutical Diagnostics business of GE HealthCare, producing contrast agents and molecular imaging tracers including Omnipaque, Clariscan, Vizamyl, and Flyrcado used in diagnostic scans worldwide.
pharmaceuticalscontrast-agentsdiagnostics
Healthcare PharmaceuticalsOtezla
Owned by Amgen Inc.
Oral medication for psoriasis and psoriatic arthritis owned by Amgen Inc., the leading non-injectable treatment in its class.
pharmaceuticalspsoriasispsoriatic-arthritis
Healthcare PharmaceuticalsProlia
Owned by Amgen Inc.
Biologic osteoporosis medication owned by Amgen Inc., the leading injectable treatment for bone density loss.
pharmaceuticalsbiologicsosteoporosis
Healthcare PharmaceuticalsTeva Pharmaceuticals
Owned by Teva Pharmaceutical Industries
Israeli multinational pharmaceutical company and the world's largest generic drug manufacturer, publicly traded on NYSE under ticker TEVA, headquartered in Tel Aviv, Israel.
generic-drugspharmaceuticalsspecialty-medicines
Competitive Analysis
Market Positioning: Pacira competes with 5 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Pacira
Looking for brands with different ownership structures? These similar brands are not owned by Pacira BioSciences, Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsTirosint
Owned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
levothyroxinehypothyroidismthyroid
Privately Owned
Tirosint is privately owned, unlike Pacira which is under a publicly traded parent company.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Pacira which is under a publicly traded parent company.
Healthcare PharmaceuticalsHCA Healthcare
Owned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
hospitalshealthcareemergency-care
Publicly Traded
HCA Healthcare operates independently without a large parent corporation.
Healthcare PharmaceuticalsPfizer
Owned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
pharmaceuticalvaccinesmedicines
Publicly Traded
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsRegeneron
Owned by Regeneron Pharmaceuticals, Inc.
Biotechnology brand of Regeneron Pharmaceuticals, developer of Eylea, Dupixent, and Libtayo, headquartered in Tarrytown, New York.
biotechnologypharmaceuticalseylea
Publicly Traded
Regeneron operates independently without a large parent corporation.
Healthcare PharmaceuticalsTylenol
Owned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
pain-reliefmedicationpharmaceutical
Privately Owned
Tylenol is privately owned, unlike Pacira which is under a publicly traded parent company.
Pacira BioSciences, Inc. Stock Information
Advertisement
Jobs at Pacira BioSciences, Inc.
Latest News About Pacira
Advertisement
Related Articles About Pacira
View more articles
Brand Comparisons
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.
Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Brand Ownership
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.
Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription